ciprofloxacin has been researched along with framycetin in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.35) | 18.7374 |
1990's | 6 (13.04) | 18.2507 |
2000's | 23 (50.00) | 29.6817 |
2010's | 14 (30.43) | 24.3611 |
2020's | 1 (2.17) | 2.80 |
Authors | Studies |
---|---|
Hall, P; Hudock, MP; Leon, A; Liu, L; Morita, CT; Oldfield, E; Puan, KJ; Studer, D; Yang, Y; Yin, F | 1 |
Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Baasov, T; Belakhov, V; Hainrichson, M; Pokrovskaya, V; Yaron, S | 1 |
Jain, R; Reddy, RP; Sharma, RK; Tegge, W | 1 |
Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Doležal, M; Kubíček, V; Kučera, R; Kuneš, J; Mandíková, J; Paterová, P; Servusová, B; Zitko, J | 1 |
Amaral, L; Bojarski, AJ; Handzlik, J; Kieć-Kononowicz, K; Latacz, G; Matys, A; Molnar, J; Otrębska-Machaj, E; Podlewska, S; Schabikowski, J; Szymańska, E; Witek, J; Witek, K | 1 |
Barros R S, V; Das, I; Décout, JL; Désiré, J; El Khoury, M; Mingeot-Leclercq, MP; Sautrey, G; Zimmermann, L | 1 |
Baasov, T; Belakhov, V; Pokrovskaya, V; Shavit, M | 1 |
Briée, F; Décout, JL; Kempf, J; Mingeot-Leclercq, MP; Swain, J; Zimmermann, L | 1 |
Aggarwal, B; Bajaj, A; Gupta, S; Gupta, SK; Jain, D; Kumar, S; Kumar, Y; Mehta, D; Pal, G; Pal, S; Rajput, K; Ramu, VS; Rana, K; Rani, P; Saini, V | 1 |
Brownlee, RE; Hulka, GF; Pillsbury, HC; Prazma, J | 1 |
Burrell, MI; Hopkins, MS; Levine, J; Schmidt, MH | 1 |
Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
Dekker, A; Rozenberg-Arska, M; Verhoef, J | 1 |
Akard, L; Allen, SD; Black, JR; Cromer, M; Jansen, J; Wheat, LJ | 1 |
Boyce, ST; Holder, IA | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Alper, CM; Bluestone, CD; Casselbrant, ML; Dohar, JE; Doyle, WJ; Kenna, MA; Rose, EA | 1 |
Bent, JP; Hebert, RL; King, GE; Vick, ML | 1 |
Doyle, JS; Fedorak, RN; Jewell, LD; Madsen, KL; Rennie, RP; Tavernini, MM | 1 |
Ghosh, SK | 1 |
Miró, N | 1 |
Church, CA; Jinn, TH; John, EO; Jung, TT; Kim, DJ; Russell, PT | 1 |
Bent, JP; Morpeth, JF; Watson, T | 1 |
Bhamra, A; Hann, IM; Kibbler, CC; Nazareth, B; Paterson, P; Prentice, HG | 1 |
Kallioinen, M; Luotonen, J; Luotonen, L; Tapiainen, T | 1 |
Deitmer, T | 1 |
Couzos, S; Culbong, M; Lea, T; Mueller, R; Murray, R | 1 |
Conroy, PJ; Dupre, SJ; Garadi, R; Henry, DC; Hogg, LG; Pien, FD; Potts, SL; Roland, PS; Schultz, CC; Stroman, DW; Wall, GM | 1 |
Taylor, G; Vaile, L; Waddell, A; Williamson, T | 1 |
Rahman, A; Rizwan, S; Wall, GM; Waycaster, C | 1 |
Gadil, E; Leach, A; Morris, P; Stubbs, E; Wood, Y | 1 |
Drehobl, M; Goldstein, G; Guerrero, JL; Lacarte, PR; Luber, S; Mata, FS | 1 |
Cannon, M; Cernigliaro, J; Jurado, R; Percinoto, C; Vieira, A | 1 |
Dohar, JE; McLean, C; Roland, P; Stroman, DW; Wall, GM | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Crowson, MG; Schulz, K; Tucci, DL | 1 |
Taylor, GJ; Vaile, L; Waddell, A; Williamson, T | 1 |
Antonelli, PJ; Dirain, CO; Kosko, B | 1 |
Antonelli, PJ; Dirain, CO; Karnani, DN | 1 |
4 review(s) available for ciprofloxacin and framycetin
Article | Year |
---|---|
Topical and systemic treatment for chronic suppurative otitis media.
Topics: Administration, Oral; Administration, Topical; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Neomycin; Otitis Media, Suppurative; Polymyxins; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome | 2002 |
Interventions for ear discharge associated with grommets (ventilation tubes).
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cerebrospinal Fluid Otorrhea; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Randomized Controlled Trials as Topic; Tympanic Membrane Perforation | 2006 |
Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Middle Aged; Neomycin; Otitis Externa; Polymyxin B; Suspensions; Treatment Outcome | 2007 |
WITHDRAWN: Interventions for ear discharge associated with grommets (ventilation tubes).
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cerebrospinal Fluid Otorrhea; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Randomized Controlled Trials as Topic; Tympanic Membrane Perforation | 2016 |
9 trial(s) available for ciprofloxacin and framycetin
Article | Year |
---|---|
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Infection Control; Leukemia; Neomycin; Neutropenia; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Marrow Diseases; Ciprofloxacin; Drug Therapy, Combination; Female; Granulocytes; Humans; Intestines; Leukocyte Count; Male; Middle Aged; Nalidixic Acid; Neomycin; Patient Compliance; Polymyxin B; Treatment Outcome | 1994 |
Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Combinations; Female; Humans; Hydrocortisone; Male; Microbial Sensitivity Tests; Middle Aged; Neomycin; Otitis Media, Suppurative; Polymyxin B; Prospective Studies; Treatment Outcome | 2000 |
A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea.
Topics: Administration, Topical; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Confidence Intervals; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Male; Middle Ear Ventilation; Neomycin; Otitis Media with Effusion; Polymyxin B; Probability; Reference Values; Treatment Outcome | 2001 |
Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; Middle Aged; Neomycin; Neutropenia; Statistics, Nonparametric; Transplantation Conditioning; Treatment Outcome | 2001 |
Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Community Health Services; Dexamethasone; Drug Administration Schedule; Female; Framycetin; Gramicidin; Humans; Infant; Male; Native Hawaiian or Other Pacific Islander; Otitis Media, Suppurative; Povidone-Iodine; Queensland; Treatment Outcome; Western Australia | 2003 |
Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Female; Framycetin; Humans; Infant; Male; Middle Aged; Otitis Externa; Pharmaceutical Solutions; Polymyxin B; Single-Blind Method; Treatment Outcome | 2004 |
Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Australia; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; Framycetin; Gramicidin; Humans; Infant; Male; Native Hawaiian or Other Pacific Islander; Otitis Media, Suppurative; Treatment Outcome | 2008 |
Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Female; Humans; Hydrocortisone; Male; Middle Aged; Neomycin; Otitis Externa; Pharmaceutical Solutions; Polymyxin B; Spain; United States | 2008 |
33 other study(ies) available for ciprofloxacin and framycetin
Article | Year |
---|---|
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Topics: Anti-Bacterial Agents; Cluster Analysis; Diphosphonates; Drug Synergism; Escherichia coli K12; Fosfomycin; Gene Expression; Geranyltranstransferase; Models, Molecular; Oligonucleotide Array Sequence Analysis; Quantitative Structure-Activity Relationship; Terpenes | 2006 |
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Topoisomerase IV; Drug Design; Drug Resistance, Bacterial; Framycetin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2009 |
Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Topics: Antimicrobial Cationic Peptides; Bacteria; Dipeptides; Drug Discovery; Fungi; Microbial Sensitivity Tests | 2009 |
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Crystallography; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide | 2014 |
Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: synthesis, biological evaluation and molecular modeling studies.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Imidazolidines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2015 |
New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Framycetin; Glucosamine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface-Active Agents | 2016 |
Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Kanamycin; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Eukaryotic Cells; Framycetin; Humans; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship; Surface-Active Agents | 2018 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Operon; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Ciprofloxacin. Use as a topical otic preparation.
Topics: Administration, Topical; Animals; Auditory Threshold; Ciprofloxacin; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Conductive; Neomycin; Sodium Chloride | 1992 |
Acute jejunoileitis. A distinct entity?
Topics: Adult; Barium Sulfate; Ciprofloxacin; Diagnosis, Differential; Enteritis; Erythromycin; Humans; Ileitis; Intestinal Obstruction; Jejunal Diseases; Male; Methylprednisolone Hemisuccinate; Neomycin; Prednisone; Tomography, X-Ray Computed | 1992 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
Formulation of 'idealized' topical antimicrobial mixtures for use with cultured skin grafts.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mupirocin; Neomycin; Nystatin; Polymyxin B; Pseudomonas aeruginosa; Skin; Skin Transplantation; Staphylococcus aureus | 1996 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Treatment of chronic suppurative otitis media with topical ciprofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Combinations; Humans; Hydrocortisone; Macaca fascicularis; Neomycin; Otitis Media, Suppurative; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 1998 |
Tympanostomy tubes and otic suspensions: do they reach the middle ear space?
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Drug Combinations; Ear, Middle; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Postoperative Complications; Therapeutic Irrigation; Tobramycin | 2000 |
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.
Topics: Age Factors; Animals; Anti-Bacterial Agents; Bacteroides; Ciprofloxacin; Clostridium; Colitis; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Interleukin-10; Intestinal Mucosa; Lactobacillus; Longitudinal Studies; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Neomycin; Streptococcus | 2000 |
A rare infection caused by Chryseomonas luteola.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Diabetes Complications; Drug Combinations; Female; HIV Infections; Humans; Immunocompromised Host; Liver Diseases; Nasal Septum; Neomycin; Pancreatitis; Pneumonia; Pseudomonas Infections; Skin Diseases, Bacterial; Ulcer | 2000 |
Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells.
Topics: Administration, Topical; Animals; Cell Survival; Cells, Cultured; Chinchilla; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Hair Cells, Auditory, Outer; Hydrocortisone; Neomycin; Ofloxacin; Polymyxin B | 2001 |
Tularemia of the middle ear.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Antigens, Bacterial; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Framycetin; Francisella tularensis; Gramicidin; Humans; Male; Otitis Media, Suppurative; Tularemia | 2002 |
Effects of antibacterial agents on dental pulps of monkeys mechanically exposed and contaminated.
Topics: Aluminum Compounds; Animals; Anti-Bacterial Agents; Bicuspid; Calcium Compounds; Cebus; Ciprofloxacin; Dental Cements; Dental Pulp; Dental Pulp Capping; Dental Pulp Exposure; Dental Pulp Necrosis; Drug Combinations; Formocresols; Glass Ionomer Cements; Hydrocortisone; Male; Mandible; Maxilla; Neomycin; Oxides; Polymyxin B; Pulpotomy; Resins, Synthetic; Silicates | 2008 |
Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Topics: Acute Disease; Administration, Topical; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Neomycin; Otitis Externa; Polymyxin B; Pseudomonas aeruginosa; Staphylococcus aureus | 2009 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
National Utilization and Forecasting of Ototopical Antibiotics: Medicaid Data Versus "Dr. Google".
Topics: Anti-Bacterial Agents; Ciprofloxacin; Databases, Factual; Dexamethasone; Drug Combinations; Forecasting; Humans; Hydrocortisone; Internet; Male; Medicaid; Neomycin; Ofloxacin; Otitis Externa; Polymyxin B; Practice Patterns, Physicians'; Seasons; United States | 2016 |
Effects of Common Ear Drops on Tympanic Membrane Healing in Rats.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Glucocorticoids; Instillation, Drug; Male; Neomycin; Ofloxacin; Rats; Rats, Sprague-Dawley; Time Factors; Tympanic Membrane Perforation; Wound Healing | 2018 |
Commercial Quinolone Ear Drops Cause Perforations in Intact Rat Tympanic Membranes.
Topics: Animals; Ciprofloxacin; Dexamethasone; Female; Hydrocortisone; Male; Methylprednisolone Hemisuccinate; Middle Ear Ventilation; Neomycin; Ofloxacin; Prostheses and Implants; Quinolones; Random Allocation; Rats; Rats, Sprague-Dawley; Tympanic Membrane; Tympanic Membrane Perforation | 2019 |